The metabolic syndrome in cancer survivors - PubMed (original) (raw)
Review
The metabolic syndrome in cancer survivors
Esther C de Haas et al. Lancet Oncol. 2010 Feb.
Abstract
The metabolic syndrome, as a cluster of cardiovascular risk factors, may represent an important connection between cancer treatment and its common late effect of cardiovascular disease. Insight into the aetiology of the metabolic syndrome after cancer treatment might help to identify and treat cancer survivors with increased cardiovascular risk. In this review, we summarise current knowledge on the prevalence and pathophysiology of the metabolic syndrome in cancer survivors, and discuss current intervention strategies with an emphasis on new developments.
Copyright 2010 Elsevier Ltd. All rights reserved.
Comment in
- On treating metabolic syndrome: emphasise lifestyle change.
Goldstein MR, Mascitelli L, Pezzetta F. Goldstein MR, et al. Lancet Oncol. 2010 May;11(5):415. doi: 10.1016/S1470-2045(10)70055-3. Lancet Oncol. 2010. PMID: 20434715 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical